On the contrary, in J20 mice, an AD-like model expressing mutated APP (K670N/M671L/V717F), Koppel et al. found that CB2 lacking mice exhibited increased Aβ deposits in the cerebral cortex, hippocampus and enhanced plaque-associated microglia [160]. Here, CNR2 is linked to Alzheimer disease.